145 related articles for article (PubMed ID: 3079084)
1. Development of anti-idiotypic antibodies to HLA antigens in human hepatic allograft tolerance.
Mohanakumar T; Hoover SK; Rhodes C; Mendez-Picon G; Flye MW; Lee HM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2437-9. PubMed ID: 3079084
[No Abstract] [Full Text] [Related]
2. Anti-idiotypic antibodies regulate the immune response to HLA in heart allograft recipients.
Reed E; Rouah C; Hsu D; Cechova K; Rose E; Smith C; Reemstma K; King DW; Suciu-Foca N
Transplant Proc; 1989 Feb; 21(1 Pt 1):463-4. PubMed ID: 2650178
[No Abstract] [Full Text] [Related]
3. Development of class I-directed lymphocytotoxic antibodies after liver transplantation.
Bryan CF; Newman JT; Tillquist RL; Husberg B; Klintmalm GB; Stone MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2392-3. PubMed ID: 3274523
[No Abstract] [Full Text] [Related]
4. Idiotypic network regulations of immune responses to HLA.
Suciu-Foca N; Rohowsky-Kochan C; Reed E; Haars R; Bonagura V; King DW; Reemstma K
Fed Proc; 1985 May; 44(8):2483-7. PubMed ID: 3157602
[TBL] [Abstract][Full Text] [Related]
5. Monitoring after transplantation in liver and kidney transplant recipients with anti-donor HLA antibodies.
Torlone N; Piazza A; Valeri M; Tisone G; Poggi E; Provenzani L; Monaco PI; Adorno D; Casciani CU
Transplant Proc; 1993 Dec; 25(6):3275-6. PubMed ID: 8266540
[No Abstract] [Full Text] [Related]
6. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)].
Drannik GN; Driianskaia VE
Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199
[No Abstract] [Full Text] [Related]
7. Anti-donor's B lymphocytes and anti-IgG antibodies in kidney allograft recipients: correlative study with the transplant outcome.
de Mouzon A; Soulillou JP; Blanc M; Durand D; Ohayon E; Ducos J
Transplant Proc; 1979 Jun; 11(2):1267-8. PubMed ID: 382504
[No Abstract] [Full Text] [Related]
8. Antiidiotypic antibodies: production in vitro by EBV-transformed lymphoblastoid cell lines and immunochemical characterization of idiotypic receptors on T-cells.
Singal DP; Joseph S; Frame B; Ludwin D; Mervart H; Blajchman MA
Transplant Proc; 1989 Feb; 21(1 Pt 1):333-5. PubMed ID: 2539669
[No Abstract] [Full Text] [Related]
9. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
[TBL] [Abstract][Full Text] [Related]
10. Results of transplantation with remote-positive proximate-negative T cell antiglobulin crossmatches.
Hodge E; Novick A; Lewis R; Steinmuller D; Streem S; Cunningham R; Braun W; Zachary A; Protiva D
Transplant Proc; 1987 Feb; 19(1 Pt 1):789-91. PubMed ID: 3274874
[No Abstract] [Full Text] [Related]
11. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
Grimm PC; Sekiya NM; Robertson LS; Robinson BJ; Ettenger RB
Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
[No Abstract] [Full Text] [Related]
12. Monitoring of allograft recipients for the development of HLA-specific antibodies: elimination of OKT3 as a complicating factor.
Mulligan D; Gentry L; Dombrausky L; Klintmalm G; Nikaein A
Clin Transplant; 1995 Dec; 9(6):438-41. PubMed ID: 8645885
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotypic antibodies to HLA after donor-specific blood transfusion (DST).
Pohanka E; Manfro RC; Oto C; Colombe BW; Melzer J; Feduska N; Salvatierra O; Garovoy MR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1806-9. PubMed ID: 2652590
[No Abstract] [Full Text] [Related]
14. Development of anti-idiotypic antibodies to HLA antigens during pregnancy.
Agrawal S; Sharma RK; Kishore R; Agarwal SS
Indian J Med Res; 1994 Jan; 99():42-6. PubMed ID: 8163301
[TBL] [Abstract][Full Text] [Related]
15. Immunological monitoring of heart allograft recipients.
Lungu O; Reed E; Smith C; Rose E; Marboe C; Hardy M; Reemtsma K; Fenoglio J; Suciu-Foca N
Transplant Proc; 1987 Feb; 19(1 Pt 3):2548-50. PubMed ID: 3274560
[No Abstract] [Full Text] [Related]
16. Immunology of acute and chronic hepatic allograft rejection.
Vierling JM
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S1-S20. PubMed ID: 10431013
[No Abstract] [Full Text] [Related]
17. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
[TBL] [Abstract][Full Text] [Related]
18. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
19. Prediction of humoral immune responses to HLA through antiidiotypic antibody studies.
Reed E; McManus P; Ho E; Benvenisty A; Hardy M; McCabe R; Brensilver J; King DW; Suciu-Foca N
Transplant Proc; 1989 Feb; 21(1 Pt 1):708-10. PubMed ID: 2650235
[No Abstract] [Full Text] [Related]
20. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporine A.
Stewart KN; Power DA; Hills AN; Catto GR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2262-3. PubMed ID: 3079078
[No Abstract] [Full Text] [Related]
[Next] [New Search]
